Teva May Increase Mylan Proposal to $43B This Week

This takeover proposal would mark the drug industry’s largest this year

July 8, 2015

Bloomberg reported that Teva Pharmaceutical Industries Ltd. will likely increase its bid for rival Mylan NV by as much as $2 billion, to $43 billion, and may announce the new proposal as soon as this week.

Teva may offer $86 to $88 a share for Mylan, said unnamed sources. That compares with the $82 a share Teva offered in April, a price that valued the Canonsburg, Pennsylvania-based company at about $40.1 billion, the article said. Mylan had a market value of about $34.4 billion as of last week’s close.

Read the full story